NOVAVAX, INC.

• NOVAVAX, INC $1,090,000 In-house, the client's own filings · 7 filings
• BALLARD PARTNERS $350,000 Outside firm · 8 filings
• BROWNSTEIN HYATT FARBER SCHRECK, LLP $230,000 Outside firm · 6 filings
• CROWELL & MORING LLP $100,000 Outside firm · 4 filings
• JEFFREY J. KIMBELL & ASSOCIATES, INC. $90,000 Outside firm · 4 filings
• CROSSROADS STRATEGIES, LLC $70,000 Outside firm · 2 filings

Spend per registrant: fees an outside firm reported, or the costs the client reported for lobbying in-house. The rows add up to the total above.

• H.R. 4121
  Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026
  3 filings
• H. Con. Res. 14
  Establishing the congressional budget for the United States Government for fiscal year 2025 and setting forth…
  1 filing
• H.R. 1968
  Full-Year Continuing Appropriations and Extensions Act, 2025
  1 filing

• 2026 $690,000 9 filings
• 2025 $1,240,000 22 filings

• Health Issues 21
• Medical/Disease Research/Clinical Labs 8
• Budget/Appropriations 2
• Trade (domestic/foreign) 2

The count is how many filings named that issue area. A filing reports one lump figure covering every issue on it, so the money above cannot be split between them.

• HOUSE OF REPRESENTATIVES 25
• SENATE 25
• Health & Human Services, Dept of (HHS) 5
• White House Office 5
• Natl Institutes of Health (NIH) 2
• Executive Office of the President (EOP) 1